No screen carries Carl Icahn’s authorization. What gets sold under that name is an activist-flavoured preset – usually cheap on assets, paying something in dividends, with insiders holding a chunk and institutions holding comparatively little – assembled by whoever maintains the site rather than by anyone who has met him. The underlying instinct is nonetheless worth understanding, because it points at something ratios alone cannot see: sometimes a business is worth more than its shares trade for and requires somebody with power to force the gap closed. That requirement is the difference between value investing and activism, and it explains most of the preset’s flaws too.
What the filters actually select for
Cheap against book value finds capital-heavy businesses whose assets markets doubt: banks, insurers, shipping, steel, regional retailers. Sometimes asset values are understated and sometimes the assets earn less than they cost to maintain – the ratio means opposite things depending on the business, which is why sorting on it alone mostly ranks industries by how much machinery they own.
High dividend yield frequently marks a payout investors expect to be cut. Yields rise when prices fall, so the top of any yield-sorted list concentrates trouble: cyclicals at peak earnings about to normalise, leveraged issuers whose cover is thinning, companies paying out anyway to defend appearances. Dividend safety has its own tests – coverage, funding source, whether profit rises at all – and none of them appear in the filter.
Heavy insider holdings can mean founders aligned with owners, which is genuinely favourable, or boards so entrenched that outside holders have no mechanism to change anything. Control is valuable precisely because it decides what happens when strategy disappoints; concentration tells you who decides, not whether they decide well. Distinguish founders whose wealth rides on the outcome from directors collecting fees for attendance.
Light institutional ownership is the most defensible element, since thinly covered companies get less analytical competition and mispricings survive longer there. It also explains the whole approach’s constraint: institutions avoid such names for reasons – liquidity, mandates, governance concerns, size limits – some legitimate, some careerist. Low ownership is a hunting ground, never a verdict.
What activism adds, and what it costs
The premise behind the disruption half is that prices sometimes sit below what a business could produce under different decisions: capital returned instead of hoarded, divisions sold rather than cross-subsidised, costs addressed before erosion compounds, poor acquisitions stopped. Public campaigns attempt those outcomes through shareholder proposals, director elections, negotiated board representation and private pressure. Outcomes vary widely, and the visible successes get studied endlessly while the unsuccessful campaigns – capital spent, management antagonised, years absorbed – rarely generate articles. Legally, investors accumulating meaningful positions cross disclosure thresholds and file publicly within days, so following those documents beats waiting for press coverage; several regimes distinguish someone intending to influence decisions from a holder staying passive, and that distinction changes what must be revealed and when.
For a beginner the practical use of this genre is informational rather than imitative. You cannot mount a campaign, and copying a disclosed stake buys you the position without the leverage that made it interesting – buying after the activist announces converts somebody else’s work into your entry price, usually a substantial premium. What you can do is read those filings as free research signals, then evaluate the target on fundamentals: does the criticism identify something observable in the statements, such as cash accumulating earning nothing while borrowings carry higher rates, or returns on invested capital below the cost of the money being raised? If the diagnosis matches what the filings themselves show, the thesis deserves study independently of who raised it.
Then apply the standard discipline: write down what specifically must change, who possesses the ability to change it, how long that plausibly takes, and what happens if nothing changes at all. Campaigns run for years, and a plan whose only exit is somebody else acting contains a dependency you don’t control. Anything else amounts to betting on a personality rather than analysing a business, which is the difference between screening on cheapness plus evidence and screening on cheapness plus excitement. A handful of famous operators built reputations doing this combatively; people copying their disclosed trades afterward generally collected worse prices, longer waiting periods and no way of forcing resolution, while the ones who lost money quietly had no article written about them. Whatever tool carries a celebrity’s name, the load-bearing question stays local to the company: is there a concrete, evidenced gap between what this earns and what it could earn under better decisions, and can you survive the period before anyone acts on it? Verify any such reasoning against your own valuation work, not against headlines describing someone else’s.
This is educational discussion of screening conventions and shareholder activism, not financial advice or a recommendation to buy or sell anything; preset thresholds shown anywhere belong to whoever published them rather than to any investor named here, nobody’s disclosed position constitutes a recommendation, investing involves risk, and cheap-looking stocks frequently stay cheap while paying dividends until they cannot.